Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Mereo BioPharma Group Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Mereo BioPharma Group · Mereo BioPharma securities · Ongoing Litigation

Last updated

Case overview

Defendant company
Mereo BioPharma Group
Product or service
Mereo BioPharma securities
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Application

Participation information

Availability is based on each listed participation option and its deadline.

Lead Plaintiff Application

Investors who purchased Mereo BioPharma Group securities between June 5, 2023 and December 26, 2025, inclusive, and suffered a loss were encouraged to contact the Schall Law Firm.

Contact the Schall Law Firm regarding the opportunity to lead the lawsuit.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Rosen Law Firm investor inquiry

Purchasers of Mereo BioPharma Group American Depositary Shares between June 5, 2023, and December 26, 2025, including investors with losses in excess of $100,000.

Contact Rosen Law Firm for information about investor rights.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear
Original article

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.